Cabaletta Bio (CABA) remains a Buy: rese-cel trial catalysts, autoimmune upside, scalable manufacturing, and key risks like ...
Major operational milestone achieved as Incannex advances late-stage development of IHL-42X, with all clinical sites identified and trial infrastructure activated ...
Interac Corp. (Interac) and Billboard Canada today announced a new collaboration at North by Northeast (NXNE) to spotlight and support the small businesses that power Canada's music ecosystem.At the ...
Operating expenses increased to $3.7 million in Q1 2026 compared to $2.8 million in 2025. The company is scaling sales and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results